Thank you for submitting your manuscript for consideration by The EMBO Journal. Let me first of all apologise for the delay in getting back to you with a decision. Unfortunately, we experienced difficulties with the availability of suitable and willing referees.
Three referees have now evaluated the manuscript and their comments are shown below. As you will see while referee 1 is not in favour of publication of the study here the other two referees are very positive and offer strong support for publication of the study. I would thus like to invite you to prepare a revised manuscript in which you need to address the issues raised by the referees in an adequate manner. Furthermore, I need to ask you to include the accession details for the PDB entry at this point.
I should remind you that it is EMBO Journal policy to allow a single round of revision only and that, therefore, acceptance of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Peer Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process initiative, please visit our website: http://www.nature.com/emboj/about/process.html Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor The EMBO Journal REFEREE REPORTS Referee #1 (Remarks to the Author):
The manuscript by Ren and Hurley describes the crystal structure of the yeast UEV domain of ESCRT-I Vps23 in complex with a peptide derived from yeast ESCRT-0 Vps27. The structure reveals a new binding site on the UEV domain that differs from the previously determined interaction site specific for the PT/SAP motif present in human ESCRT-0 and HIV-1 Gag p6. Although mutagenesis of the interaction site disrupts binding in vitro, it is not essential for Cps1 cargo sorting.
The authors also present the unliganded structure of the UEV domain, which reveals some conformational flexibility within beta strands 2 and 3, as shown previously for human Tsg101 UEV. They further compare the unliganded UEV, PSDP liganded UEV and the UEV-ubiquitin structure, which reveals no substantial structural changes except for the ubiquitin binding site.
The majority of the paper describes the interaction of the peptide and the small structural changes observed in different UEV structures in great detail. Although these details might be of interest for structural biologists, they add little to the understanding of ESCRT-I or ESCRT-0 function.
ITC analysis showed that the peptides bind with a rather low affinity -14 and 84 µM. The Trp16 mutation abrogates binding. What is the role of Asp449? The HRS PSAP peptide does not have the same flanking sequences as the PSDP peptide and is thus not a good control for the Asp449 mutation. Is it possible that the flanking sequences of HRS PSAP prevent binding?
The authors then show that the Trp mutant shows some sorting defect in Vps4 negative cells. The image in D hints at concentration of Vps23 in perinuclear region? Could D resemble C at lower fluorescence intensity? The role of the motif remains unclear because sorting of several receptors, Csp1 (in this manuscript) and Ste3 and Fth1-Ub is normal in the absence of a functional sequence motif.
In conclusion, the structural analysis of the UEV-peptide interaction is sound and interesting for structural biologists, but reveals little about the function of this potential motif in receptor sorting.
Minor points:
Page 5 : " the main chain carbonyl of Vps27 Ser448 forms a beta-sheet hydrogen bonds with .." This should probably read : the main chain carbonyl of Vps27 Ser448 forms a hydrogen bond ... The subsequent description of the hydrogen bond network is confusing. Figure 2D does not indicate a hydrogen bond between Ser448 NH and the hydroxyl of the Thr49 side chain; looks like the Thr49 CO The description of the binding mode as an extension of the UEV beta-sheet looks like an overinterpretation with only one NH-CO contact.
Page 7 ; The hairpin turn connecting beta 1 and beta 2 is involved in ubiquitin binding ... The manuscript of Ren ad Hurley describes binding of the Vps23 UEV domain to a PSDP peptide from Vps27. The structure of the UEV domain is well known from previous work for both the yeast and human ESCRT-I, from both the work of Hurley and others. What is new in this manuscript is the site of the PSDP-peptide binding on the UEV domain. This site is in a very different location than the previously reported P(T/S)AP binding site reported for the Tsg101 UEV, and the binding site helps to rationalize previous structure-based observations. The discussion at the bottom of p. 10 beginning "It is truly remarkable..." is somewhat of an overstatement. The idea of similar motifs binding at different sites on a given type of domain is not really unique. In the ESCRT field, ESCRT-III peptides bind in two different sites on the Vps4 MIT domain (MIM1 vs MI2 binding site). It is a matter of how similar the motifs are and what constitutes "completely different structural sites". It is a frustratingly difficult to rationalize observation but completely consistent with previous reports that loss of the ESCRT-0/ESCRT-I interaction by point mutations seems to have no effect on cargo sorting, although the authors show that the mutant ESCRT-0 does not support localization of the ESCRT-I to class E compartments in a strain without Vps4.
The manuscript is succinct and informative. It is a very nice completion of a store that has had some clear missing elements. The EMBO readership should find it interesting.
Referee #3 (Remarks to the Author):
The interaction between the Vsp27 subunit of the ESCRT-0 complex and the UEV domain of the Vps23 subunit of the ESCRT-1 complex functions in the ESCRT pathway, and is therefore important for the budding vesicles (and their cargo) into late endosomes. In animal cells the same pathway also functions in cytokinesis and in the budding of HIV and many other enveloped viruses. The interaction in human cells has been previously characterized in detail by structure determination, although there were hints that molecular details of the interaction are different in yeasts. Ren and Hurley now reveal the nature of this interaction in yeasts by determining the crystal structure of S.cerevisae Vps23 UEV domain alone and in complex with a peptide from Vps27. ITC and mutagenesis are used to verify that the interaction seen in the crystal structure also applies in solution, and localization experiments support a functional role for the interaction characterized. The primary finding is that the interaction in yeast is indeed quite different from that of the human proteins; the Vps27 peptide sequence is different and it binds to a different part of the UEV domain. This work therefore provides a striking example of how homologous protein partners have maintained their interaction throughout evolution but have radically remodeled the molecular details of their interface.
In general the technical aspects of this study are of high quality. The data in figure 4 is presented without any quantification that I could see in the manuscript. A blind scoring scheme should be used to quantify the number of cells displaying the class E phenotype for the mutant and control. 
Referee #1 (Remarks to the Author):
We appreciate this referee's constructive suggestions and corrections.
ITC analysis showed that the peptides bind with a rather low affinity -14 and 84 uM. The Trp16 mutation abrogates binding. What is the role of Asp449? The HRS PSAP peptide does not have the same flanking sequences as the PSDP peptide and is thus not a good control for the Asp449 mutation. Is it possible that the flanking sequences of HRS PSAP prevent binding?
Binding of an Asp->Ala peptide mutant was assayed and showed a 16-fold reduction in affinity compared to wild-type (new Figure 3B) . Note in order to avoid delay in resubmission due to waiting for custom synthesized peptide, this experiment was done using GB1 fusion constructs. We show in Fig. 3B that the GB1 partner does not interact with the UEV domain, and has a negligible effect on the peptide affinity.
The authors then show that the Trp mutant shows some sorting defect in Vps4 negative cells.
To be precise, we show there is a defect in Vps23 localization. There was no defect in the sorting of the Cps1 cargo that was examined.
The image in D hints at concentration of Vps23 in perinuclear region?
We are not entirely sure what features are being referred to. Our impression is the referee is mainly concerned that we are not misinterpreting the phenotype shown images in D vs. C, which we address below.
Could D resemble C at lower fluorescence intensity?
These differences were analyzed more quantitatively using the blind scoring procedure suggested by ref.
3, and the results incorporated into Fig. 4 . There are 1.4 puncta per cell for wild-type Vps23 but only 0.2 for the W16A mutant, after blind counting of over 500 cells. Changing intensity does not affect these conclusions. The subsequent description of the hydrogen bond network is confusing. Figure 2D does not indicate a hydrogen bond between Ser448 NH and the hydroxyl of the Thr49 side chain; looks like the Thr49 CO It really is the side chain. We added a label to the Ogamma atom in Fig. 2D to make this clearer.
The description of the binding mode as an extension of the UEV beta-sheet looks like an overinterpretation with only one NH-CO contact.
We have removed this comment. 
What is the binding stoichiometry?
These numbers range from 1.1 to 1.3 indicating essentially 1:1 stoichiometry, consistent with the structure. These numbers have been added to Fig. 3 .
Referee #2 (Remarks to the Author):
The In general the technical aspects of this study are of high quality. We thank the referee for the kind comments.
The data in figure 4 is presented without any quantification that I could see in the manuscript. A blind scoring scheme should be used to quantify the number of cells displaying the class E phenotype for the mutant and control. This has been done. There are 1.4 puncta per cell for wild-type Vps23 but only 0.2 for the W16A mutant, after blind counting of puncta in over 500 cells. Since we are well under the space limit for an article, and we feel these figures are key to connect the structural work to the biology, we have left this material in the main text, but of course we are open to editorial input.
